We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Costs and consequences of clopidogrel versus aspirin for secondary prevention of ischaemic events in (high-risk) atherosclerotic patients in Sweden: a lifetime model based on the CAPRIE trial and high-risk CAPRIE subpopulations.
- Authors
Logman, J Floris S; Heeg, Bart M S; Herlitz, Johan; van Hout, Ben A
- Abstract
Antiplatelet therapy plays a central role in the prevention of atherothrombotic events. Both acetylsalicylic acid (aspirin) and clopidogrel have been shown to reduce the risk of recurrent cardiovascular events in various subgroups of patients with vascular disease.
- Publication
Applied health economics and health policy, 2010, Vol 8, Issue 4, p251
- ISSN
1175-5652
- Publication type
Journal Article
- DOI
10.2165/11535520-000000000-00000